Note: Ingredients listed on restricted chemical lists
EC/CAS
119-36-8
Name of the chemical
Methyl salicylate
Concentration
16.5
EC/CAS
89-78-1
Name of the chemical
Menthol; dl-menthol; l-menthol; d-menthol (40)
Concentration
3.3
EC/CAS
128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
0.1
General Information
Revision date
2022-03-09
Product name
IODEX HERBAL GEL (MFC70131)
Product Synonyms
PROJECT IODEX HERBAL GEL * MFC70131 (MFR/EXT/024) * KUNDURU NIRYASA
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Canada
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
Physical hazards
Not classified.
Health hazards
Serious eye damage/eye irritation Category 1 Sensitization, skin Category 1
Environmental hazards
Hazardous to the aquatic environment, Category 3
Signal word
Danger
Hazard statements
May cause an allergic skin reaction. Causes serious eye damage. Harmful to aquatic life with long lasting effects.
Prevention
Avoid breathing mist/vapours. Contaminated work clothing should not be allowed out of the workplace. Avoid release to the environment. Wear eye protection/face protection. Wear protective gloves.
Response
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTRE/doctor/. Specific treatment (see instruction on this label). If skin irritation or rash occurs: Get medical advice/attention. Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
7 % of the mixture consists of component(s) of unknown acute oral toxicity. 10.85 % of the mixture consists of component(s) of unknown acute dermal toxicity. 5.5 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 7 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 5.5 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
